FSSAI Suspends Six Nutraceutical Firms Over Safety Flaws
The Food Safety and Standards Authority of India has launched sweeping regulatory action against six companies for serious nutraceutical safety violations. Consequently, the national food safety regulator suspended manufacturing licenses after detecting alarming non-compliance during routine quality checks. These violations present direct risks to consumers who regularly consume dietary supplements.
Key Findings and Regulatory Enforcement
Regulators inspected production sites across India. Specifically, the enforcement targeted Airen Herbals, Aquabliss Lifesciences, Raskam Healthcare, Supercure Biotech, Ambico Ayurvedic Healthcare, and Vedant Remedies. During these audits, officials found egregious deviations from established food safety regulations. For example, several facilities stored expired raw materials in unsanitary environments. In addition, inspectors observed substandard record-keeping and poor manufacturing hygiene. As a result, the authority promptly issued license suspensions to halt unsafe batches from reaching retail pharmacies.
Nutraceutical Safety Violations and Health Risks
These recent nutraceutical safety violations raise major public health concerns. Laboratory analyses revealed that several products contained micronutrients far above permissible Recommended Dietary Allowance limits. For instance, inspectors detected toxic concentrations of biotin, zinc, selenium, copper, and fat-soluble vitamins. Furthermore, some formulations contained unapproved botanical substances like unauthorized Shilajit extracts. Other manufacturers marketed products with false therapeutic claims for chronic joint pain. Consequently, consumers faced severe risks of chronic micronutrient toxicity and unexpected allergic reactions.
Clinical Implications for Healthcare Providers
Physicians in India routinely encounter patients who self-administer over-the-counter dietary supplements. Therefore, clinicians must actively question patients about their current supplement regimens during routine consultations. Excessive intake of fat-soluble vitamins and heavy metals can trigger hepatic and renal complications. Moreover, unapproved additives can alter the pharmacokinetic profiles of prescription medications. Thus, doctors should advise patients to purchase only verified products from compliant manufacturers. When patients display unexplained toxicities, clinicians must consider adulterated or hyper-concentrated supplements as potential culprits.
Frequently Asked Questions
Q1: Why did the FSSAI take action against these nutraceutical companies?
The authority intervened after discovering expired raw materials, poor sanitation, unapproved ingredients, and micronutrient concentrations exceeding statutory safety limits.
Q2: What clinical risks arise from excessive micronutrients in dietary supplements?
Excessive intake of vitamins and trace minerals causes toxicity, leading to liver dysfunction, renal damage, and metabolic disorders.
Q3: Which manufacturing companies faced license suspensions?
The enforcement targeted Airen Herbals, Aquabliss Lifesciences, Raskam Healthcare, Supercure Biotech, Ambico Ayurvedic Healthcare, and Vedant Remedies.
References
- FSSAI action against 6 nutraceutical manufacturers for serious violations - ETHealthworld
- FSSAI acts against six nutraceutical makers over food safety violations - Business Standard
- FSSAI Cracks Down On Nutraceutical Firms Over Safety Violations, Suspends Licences - Daijiworld





